Board Of Directors


Valery Uhl, MD

Dr. Valery Uhl is a Board Certified Radiation Oncologist and trained at UCSF, specializing in both external beam and internal (brachytherapy) radiation treatment for cancer.  She is one of the first specialists in California to use Accelerated Partial Breast Irradiation (APBI) and later  Intraoperative Radiation Therapy (IORT) to treat breast cancer.  She also uses special techniques to minimize heart dose when the left breast needs radiation.  She has extensive experience in both brachytherapy and photon radiation forms of APBI and as well as Intraoperative Radiation Therapy (IORT).

Dr. Uhl is a board member and current President of the TARGIT Collaborative Group (TCG), a national organization of surgeons, radiation oncologists and medical physicists committed to improving cancer patient care through education, patient advocacy, mentorship, and collaborative research.  She gives presentations at medical meetings and also trains and proctors radiation oncologists when they initiate their IORT programs.  She developed the IORT program at Summit Medical Center in Oakland, CA and she with her team of dedicated breast surgeons participated in the TARGIT-R trial. 

Dr. Uhl's practice philosophy is “The first time you have cancer is the time to cure it!”   She believes that communicating with her patients is critical to an excellent outcome and believes in a team approach to cancer cure.  She practices in Northern California and has multiple publications, including publications on the use of IORT in patients with breast cancer.

Barry Rosen, MD, FACS

Dr. Rosen is a founding member of Advanced Surgical Care of Northern Illinois, has practiced in Chicago’s northwest suburbs for more than 25 years. His practice is currently limited to Breast Surgery.

A nationally recognized expert in oncoplastic surgery, Dr. Rosen teaches for the American Society of Breast Surgeons (ASBrS), the School of Oncoplastic Surgery, and the National Consortium of Breast Centers. Dr. Rosen is also dedicated to creating national standards for quality outcomes in breast cancer surgery, which has led to his chairmanship of the NQMBC (National Quality Metrics for Breast Centers) and his participation on the Patient Safety and Quality Committee for the ASBrS. Dr. Rosen is a board member of the TARGIT Collaborative Group, a national organization of breast surgeons and radiation oncologists dedicated to advancing Intraoperative Radiation Therapy (IORT) for breast cancer treatment, provides national training to surgical colleagues on the use of IORT, and is the Program Director for their annual international meeting. Locally, he is the Chairman of the Advocate Healthcare Breast Cancer Committee and the Medical Director of the Good Shepherd Hospital Breast Center.

Dr. Rosen’s practice philosophy is “one size fits one”—it is critical to partner with each person to determine what their goals and priorities are. Dr. Rosen believes that communicating with his patients is as important as the surgical treatment he provides. Therefore, all of his cancer patients are given his cell phone number and email address to facilitate this.


William Small, MD, FACRO, FACR, FASTRO


Dr. Small joined the Loyola University Chicago Stritch School of Medicine in July 2013 as Professor and Chair of the Department of Radiation Oncology. Prior to joining Stritch, Dr. Small was the vice chair of radiation oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He completed medical school and residency training at Northwestern University's Feinberg School of Medicine. He has been an active researcher, teacher and clinician for over 25 years.

Dr. Small has an international reputation for research and treatment of gynecological malignancies, and he specializes in treating gastrointestinal and breast cancers. He is co-chair of the NRG Oncology Gynecologic Committee, former chair of the Radiation Therapy Oncology Group (RTOG) Gynecologic Working Group, and the past chair of the Gynecologic Cancer InterGroup. Dr. Small is a fellow in the American College of Radiation Oncology, the American College of Radiology and the American Society for Radiation Oncology. The author of over 245 publications, 34 invited book chapters, and 7 books, he has been the president of the Council of Affiliated Regional Radiation Oncology Societies and the Chicago Radiological Society. Dr. Small currently serves on the Board of Chancellors of the American College of Radiology and is the Chair of the Radiation Oncology Commission. He has long been a proponent of IORT and has spoken on the use of IORT at national professional society meetings as well as at international IORT User Meetings. He is a National Co-Chair of the TARGIT US Registry clinical trial, and a member of the TARGIT Collaborative Group Board of Directors.

Anil Sethi, PhD, FAAPM

Anil Sethi, PhD is a Professor of Medical Physics and Director of Medical Physics Residency Program at Loyola University Medical Center and Loyola University Chicago, USA.   He is actively involved in education, clinical service and research.

He has authored more than 50 peer-reviewed papers and book chapters and presented more than 100 abstracts and invited talks at national and international conferences. Dr. Sethi’s research interests are in the fields of MR Guided Radiation Therapy (MRgRT), Intra-Operative Radiation Therapy (IORT), Image Guided Radiation Therapy (IGRT), Stereotactic Radiosurgery (SRS), and Stereotactic Body Radiation Therapy (SBRT). 

Dr. Sethi has been board certified in Radiation Oncology Physics and Therapeutic Radiological Physics by the American Board of Medical Physics (ABMP) and the American Board of Radiology (ABR). 

Dr. Sethi is a fellow of the American Association of Physicists in Medicine (AAPM).  He is also the recipient of the Teacher of the Year Award given by the Association of Residents in Radiation Oncology (ARRO).  He was selected a member of the ACR Commission on Medical Physics, a member of the American Board of Radiology, and a reviewer for the Radiological Society of North America (RSNA) and ABR.  He has been a past member of the AAPM working groups on Radiation Dosimetry and Treatment Planning. 

Dr. Sethi is a reviewer for a number of scientific journals, including, Physics in Medicine and Biology (PMB), Journal of Applied Clinical Medical Physics (JACMP), Physica Medica (PM), Radiation Oncology (RO), and the International Journal of Radiation Oncology, Biology and Physics (IJROBP).  He is also on the editorial boards of Medical Physics & Medical Dosimetry journals and a member of the Asia and Oceanic Affairs Committee and the Awards and Honors Committee of the AAPM.

Christine Laronga, MD, FACS

Dr. Christine Laronga is a surgical oncologist specializing in breast cancer in the Comprehensive Breast Program at the Center for Womens Oncology at Moffitt Cancer Center in Tampa, Florida. She is also the Clinical Director of Breast Surgical Oncology. Dr. Laronga enjoys making a difference in womens lives through her clinical practice and research. She treats women with all levels of breast disease, from benign cysts to metastatic breast cancer. Dr. Laronga is a principal investigator for several ground-breaking procedures, including nipple and areola skin-sparing efforts after mastectomy and liposuction for arm lymphedema resulting from breast cancer treatment. She also conducts basic research in proteomics, the study of protein markers in tissue and blood. At the national level, Dr. Laronga is a member of the National Comprehensive Cancer Network breast risk reduction panel that reviews guidelines for treating women at high risk for breast cancer. She is treasurer for the Association of Women Surgeons (an international society). She is also a member of the American Cancer Society Clinical Cancer and Epidemiology study section evaluating research grant applications. , she is a member of the National Consortium of Breast Centers and is the Florida State Chair for the American College of Surgeons Commission on Cancer. Dr. Laronga is extensively published in professional journals, has written several book chapters, speaks at numerous national and international scientific meetings, and is on the editorial board for several medical journals.

Dennis Holmes, MD, FACS

Dennis R. Holmes, M.D. is an internationally-renowned breast surgeon specializing in the surgical treatment of breast cancer and non-cancerous breast conditions. He completed his medical education at Tulane University School of Medicine, surgical residency in general surgery at the University of San Francisco, and a fellowship in breast surgery at the University of Southern California.

As a dedicated breast surgeon, Dr. Holmes has dedicated his career to breast cancer treatment innovation to reduce the burden of breast cancer care. He was a pioneering investigator in the TARGIT-A clinical trial that established the effectiveness of single-dose targeted intraoperative partial breast radiotherapy as an alternative to conventional 6-week daily whole breast radiotherapy.  He currently serves as Co-Principal Investigator of the TARGIT U.S. Registry Trial and as President of the TARGIT Collaborative Group, a national organization of surgeons, radiation oncologists, and physicists committed to improving cancer patient care through education, patient advocacy, mentorship, and collaborative research.  Dr. Holmes also serves as national principal investigator of the FROST trial, a multicenter trial evaluating the role of cryoablation or tumor freezing in the management of early stage breast cancer.

Dr. Holmes is a board-certified Fellow of the American College of Surgeons and recently held the position of Program Chair of the 20th Annual National Meeting of the American Society of Breast Surgeons.

As a sought-after physician educator, Dr. Holmes is also frequent lecturer at medical conferences around the globe. Most important to his patients, Dr. Holmes is a warm, caring breast surgeon who possesses the expertise, empathy and patience to help each patient find a breast cancer solution that suits her physically and emotionally, while providing the best possible cancer control. 

Maged Ghaly, MD

I am an associate professor at Radiation Medicine at Northwell Health's main radiation oncology program at the Center for Advanced Medicine (CFAM). My focus as a physician has been pushing novel technologies forward, and providing index measures for quality care. I have dedicated my time to further the expertise of a large interdisciplinary team - with a mission of clinical, research and teaching expertise - in the management of Head and Neck (H&N) and Central Nerves System (CNS) malignancies. 

In recent years, I collaborated with our neurosurgeons in building an interdisciplinary spine oncology program, introducing spine radiosurgery technology. In the fall of 2017, at the ASTRO annual meeting, I presented on Norwell Health's approach on the use of Kypho-Intra Operative Radiation Therapy (Kypho-IORT) for patients with pathologic spine fractures. This is a novel treatment modality we are implementing under supervision of the IRB with our neurosurgical and medical oncology colleagues and we are one of the very first programs in the U.S. utilizing this technique. 

Our curiosity has yielded several abstract presentations, research awards, and publications. 

My goals are to continue to innovate, promote research, and provide the best, most compassionate and highest quality patient care possible.

Sheldon M. Feldman, MD, FACS

Sheldon Marc Feldman, MD, is Chief, Breast Surgery and Breast Surgical Oncology and Director, Breast Cancer Services at Montefiore. He is also a Professor of Surgery at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2017, his clinical focus includes breast cancer, oncoplastic surgery with emphasis on optimizing breast conservation, nipple-sparing mastectomy, minimally invasive diagnosis and treatment, intraoperative radiation, targeted tumor ablation, lymphedema prevention, and complementary integrative holistic care with emphasis on physician-patient communication.

In 1971, Dr. Feldman received his Bachelor of Science in Biology and Psychology from State University of New York at Stony Brook. Following this, he attended the New York University Medical School where he received his Doctor of Medicine in 1975. He began his postgraduate training at NYU Medical Center, Bellevue Hospital in 1975 and spent 5 years completing an internship and residency in Surgery. He became Executive Chief Surgical Resident in 1980. Dr. Feldman then trained at Newark Beth Israel Medical Center, where he completed a fellowship in Peripheral Vascular Surgery in 1981.

Extending his clinical focus, Dr. Feldman focuses his research on targeted tumor ablation, intraoperative margin assessment, novel surgical techniques to minimize lymphedema risk, intraductal approach to breast cancer–evaluating biomarkers in nipple aspirate fluid (NAF) and intraductal diagnosis and therapy, nonsurgical treatment of ductal carcinoma, and breast cancer prevention. He has been a Principal Investigator on multiple research projects and has had his work published in books, journals and abstracts.

From 2008 to 2015, he was named a New York Super Doctor in the New York Times. He was President of the American Society of Breast Surgeons from 2016 to 2017.

Dr. Feldman is board certified by the American Board of Surgery, and he is a fellow of the American College of Surgeons. He is also a member of numerous professional societies, including the Society of Surgical Oncology, the American Society of Clinical Oncology, and the International Society of Lymphology.


Calvin Ridgeway, MD, FACS

Dr. Ridgeway grew up in Indianapolis, Indiana. He completed his undergraduate studies at Wabash College. He then went on to medical school at Tulane University in New Orleans. After that, he did his residency in general surgery in Kansas City at the University of Missouri-Truman Medical Center program. From there, he participated in the very first matching program for Surgical Oncology. This sent him to the University of Illinois @ Chicago for two years to complete his fellowship training in complex Surgical Oncology. Following his training, he went to Albuquerque, New Mexico to repay his medical school scholarship obligation to the Air Force. He has been practicing in Albuquerque ever since. During this time he has established the first NAPBC accredited breast care center in New Mexico. He also serves on the board of the New Mexico Cancer Research Alliance which facilitates bringing cooperative group clinical trials to the state. His investigations focus on new techniques and technologies that improve surgical precision and decrease treatment burden for cancer patients. 


Executive Director
Jeff Milde, CAE

Team of 5 Surgeons, 3 Radiation Oncologists and 1 Medical Physicist working together
National effort representing 5 states:
Pacific Northwest:  Northern and Southern California
Southwest: New Mexico
Mid West:  Illinois x 3
South East:  Florida
North East:  New York x 2